/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, will present data from its genetic testing portfolio at the American Society of Human.
Positive findings from genetic testing for patients with epilepsy helps guide clinical man-agement and improves patient outcomes, new research suggests.